Reynold’s brand pulls ahead as Juul Labs wrestles with regulatory uncertainty. Read More
Tags :Juul Labs
The materials would show whether the FDA balanced the health benefits and risks.Read More
The FDA's marketing denial order for Juul may have been a political decision.Read More
The case pertains to Altria’s 2018 investment in Juul, which has lost considerable value. Read More
Confusion around the FDA’s marketing denial order contributed to Juul’s retreat. Read More
The value of the investment shrivels as the FDA re-evaluates its marketing denial order.Read More
The news comes as the vapor company fights to keeps its products on the U.S. market. Read More
The announcement comes as FDA Commissioner Robert Califf attempts to push past several controversies.Read More
A spokesperson for Juul Labs told Reuters that the company is looking at options to protect its business.Read More
The agency says there are issues unique to the application that warrant additional review.Read More
